Jaguar8 commented on a stock · Oct 1, 2024 20:15

NEWS

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Allurion Technologies (NYSE: ALUR) has announced the publication of a meta-analysis demonstrating the safety and effectiveness of the Allurion Program for weight loss. The systematic review, which analyzed 11 studies involving 2,107 patients conducted between 2016 and 2024, reported an average weight reduction of 12.5% and a significant BMI reduction of 4.75 kg/m2 at four months.
The analysis also confirmed the safety of the Allurion Balloon, with a low rate of serious adverse events at just 0.90%. Additionally, the study highlighted improvements in metabolic health parameters, including HDL cholesterol, triglycerides, and glycemia. Dr. Ram Chuttani, Chief Medical Officer and Founding Partner of Allurion, emphasized that these results further support the established safety and effectiveness of the Allurion Balloon, which has been documented in 26 peer-reviewed journal articles and used to treat over 150,000 patients worldwide.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

12K Views

Comment

103314371 : I

Report
Reply

Cancel Reply

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

8158

Followers

Following

93K

Visitors